Supernus Pharmaceuticals
SUPN • NASDAQ • Stock Fundamentals
Supernus Pharmaceuticals is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Jack A. Khattar, with a market cap of $2.6B.
Market Cap$2.6B
Employees652.0
CEOJack A. Khattar
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsMay 5, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Supernus Pharmaceuticals FAQ
Common questions about Supernus Pharmaceuticals
Supernus Pharmaceuticals (SUPN) has a market capitalization of $2.6B and trades on NASDAQ.
Supernus Pharmaceuticals has approximately 652 employees.